Showing 4,041 - 4,060 results of 4,525 for search 'Long March 1', query time: 0.34s Refine Results
  1. 4041

    Adverse events associated with anti-IL-17 agents for psoriasis and psoriatic arthritis: a systematic scoping review by Jiao Wang, Jiao Wang, Chunxiao Wang, Chunxiao Wang, Liu Liu, Liu Liu, Seokgyeong Hong, Yi Ru, Xiaoying Sun, Jiale Chen, Miao Zhang, Miao Zhang, Naixuan Lin, Bin Li, Bin Li, Xin Li, Xin Li

    Published 2023-01-01
    “…BackgroundAnti-interleukin (IL)-17 biological agents (BAs) have significant efficacy in the treatment of psoriasis and psoriatic arthritis; however, adverse events (AEs) are common, and their safety has not been systematically evaluated.ObjectivesThe purpose of this systematic review and meta-analysis was to summarize the number and corresponding rates of AEs caused by anti-IL-17 BAs in patients with psoriasis and psoriatic arthritis to improve clinical decision-making regarding their use.MethodsPubMed, Embase, Cochrane Library, and Web of Science databases were independently searched by three authors for articles on the treatment of psoriasis with anti-IL-17 BAs that were published before March 1, 2022, and included at least one AE. Dichotomous variables and 95% confidence intervals (CI) were analyzed using R software (version 4.1.3) and the Meta and Metafor software packages. …”
    Get full text
    Article
  2. 4042

    Prevalence and determinants of maternal near miss in Ethiopia: a systematic review and meta-analysis, 2015–2023 by Abraham Negash, Addisu Sertsu, Dechasa Adare Mengistu, Aklilu Tamire, Adisu Birhanu Weldesenbet, Mesay Dechasa, Kabtamu Nigussie, Tilahun Bete, Elias Yadeta, Tegenu Balcha, Gebiso Roba Debele, Deribe Bekele Dechasa, Hamdi Fekredin, Habtamu Geremew, Jerman Dereje, Fikadu Tolesa, Magarsa Lami

    Published 2023-07-01
    “…Maternal near miss (MNM) resulted in long-term consequences. A systematic review and meta-analysis was performed to assess the prevalence and predictors of maternal near miss in Ethiopia from January 2015 to March 2023. …”
    Get full text
    Article
  3. 4043

    PERANAN KEJAKSAAN REPUBLIK INDONESIA DALAM PEMBERANTASAN KORUPSI DI NEGARA DEMOKRASI (Role of The Attorney General of Indonesia in Eradicating Corruption in State Democracy) by Suharyo Suharyo

    Published 2016-08-01
    “…This phenomenon triggered scholars to do long march and protest to the Attorney General to be consistent and responsive in corruption eradication. …”
    Get full text
    Article
  4. 4044

    Sustained agreement rates in the longitudinal assessment of lupus patients to a Broad Consent for personal data and specimen usage in the RHINEVIT biobank by Jutta G. Richter, Jutta G. Richter, Tim Filla, Tim Filla, Hasan Acar, Hasan Acar, Ellen Bleck, Ellen Bleck, Anna Kernder, Anna Kernder, Christina Düsing, Christina Düsing, Stefan Vordenbäumen, Stefan Vordenbäumen, Markus Schröder, Ralf Hansen, Jörg H. W. Distler, Jörg H. W. Distler, Matthias Schneider, Matthias Schneider

    Published 2023-06-01
    “…RHINEVIT's BC is successfully used for the quality-assured handling of excellently annotated biomaterial. The long-term use of these highly valuable biospecimens for unrestricted research, also in an international context, remains assured.…”
    Get full text
    Article
  5. 4045
  6. 4046
  7. 4047

    Impact of residual microcalcifcations on prognosis after neoadjuvant chemotherapy in breast cancer patients by Eun Young Kim, Kwan Ho Lee, Ji-Sup Yun, Yong Lai Park, Chan Heun Park, Sung Yoon Jang, Jai Min Ryu, Se Kyung Lee, Byung-Joo Chae, Jeong Eon Lee, Seok Won Kim, Seok Jin Nam, Jong Han Yu

    Published 2024-03-01
    “…With a median follow-up time of 71 months, compared to pCRw/o mic group, the hazard ratios (95% confidence intervals) for regional recurrence were 5.190 (1.160–23.190) in non-pCRw/mic group and 5.970 (1.840–19.380) in non-pCRw/o mic group. …”
    Get full text
    Article
  8. 4048
  9. 4049
  10. 4050
  11. 4051

    Association of atypical anti-neutrophil cytoplasmic antibody with comorbidities and outcome in a hospital-based population by Chiao-Chi Ou, Yen-Ching Wu, Jun-Peng Chen, Wen-Nan Huang, Yi-Hsing Chen, Yi-Ming Chen

    Published 2024-01-01
    “…Results: Patients with a-ANCA had lower chance of ANCA-associated vasculitis (OR: 0.02, 95 % CI: 0.01–0.07 p < 0.001), and systemic lupus erythematosus (OR: 0.23, 95 % CI: 0.11–0.48, p < 0.001), but a higher risk of rheumatoid arthritis (OR: 2.99, 95 % CI: 1.15–7.83, p = 0.025) and ulcerative colitis (OR: 5.50, 95 % CI: 1.20–25.29, p = 0.028). …”
    Get full text
    Article
  12. 4052

    Meditative-based diaphragmatic breathing vs. vagus nerve stimulation in the treatment of fibromyalgia—A randomized controlled trial: Body vs. machine by Charles Ethan Paccione, Charles Ethan Paccione, Charles Ethan Paccione, Audun Stubhaug, Audun Stubhaug, Lien My Diep, Leiv Arne Rosseland, Leiv Arne Rosseland, Henrik Børsting Jacobsen, Henrik Børsting Jacobsen

    Published 2022-11-01
    “…Further research should be conducted to evaluate potential changes in long-term cardiac-vagal heart rate variability in response to noninvasive vagus nerve innervation in those with fibromyalgia.Clinical trial registrationhttps://clinicaltrials.gov/ct2/show/NCT03180554, Identifier: NCT03180554.…”
    Get full text
    Article
  13. 4053

    Efficacy and tolerability of perampanel in patients with seizures in real-world clinical practice: A systematic review and meta-analysis by Liyan Hou, Jingjing Yang, Xuan Zhang, Na Li, Sheng Li, Lei Zhang, Jie Zhao, Qingshan Wang, Qingshan Wang

    Published 2023-03-01
    “…Objectives: The aim of this study was to systematically review the efficacy and tolerability of perampanel (PER) when used as add-on treatment or monotherapy in patients with epilepsy aged 12 years and older in routine clinical practice.Methods: Electronic and clinical trials databases were searched for observational studies of PER published up to 1 March 2022. The outcomes of interest were responder rates, adverse effects (AEs), and withdrawal rates. …”
    Get full text
    Article
  14. 4054
  15. 4055

    Antidiabetic Treatment before Hospitalization and Admission Parameters in Patients with Type 2 Diabetes, Obesity, and SARS-CoV-2 Viral Infection by Patricia-Andrada Reștea, Mariana Mureșan, Adrian Voicu, Tunde Jurca, Annamaria Pallag, Eleonora Marian, Laura Grațiela Vicaș, Ionuț I. Jeican, Carmen-Bianca Crivii

    Published 2023-02-01
    “…It is necessary for future studies to see all changes involved in antidiabetic treatment in patients with diabetes type 2 and obesity after SARS-CoV2 viral infection and its long-term evolution.…”
    Get full text
    Article
  16. 4056
  17. 4057
  18. 4058
  19. 4059
  20. 4060